<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0011633" disease_type="Disease or Syndrome" abbrv="">Dermatomyositis</z:e> (DM) has not yet been reported as a complication of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>A 50-year-old man was diagnosed as having <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> because of the presence of <z:hpo ids='HP_0001903'>anemia</z:hpo>, the appearance of immature cells in peripheral blood, and the abnormal cellular <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>A few months later, high <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0003326'>myalgia</z:hpo> and <z:hpo ids='HP_0010783'>erythema</z:hpo> developed </plain></SENT>
<SENT sid="3" pm="."><plain>Although DM symptoms were resistant to high-dose <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> administration, <z:chebi fb="0" ids="44185">methotrexate</z:chebi> (MTX) therapy improved not only the symptoms of DM but also hematologic findings related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This indicates that immunosuppressive therapy including MTX administration can be useful for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with autoimmune symptoms </plain></SENT>
</text></document>